Outcomes of Treatment With Infliximab for Ulcerative Colitis and Predictors of Sustained Clinical Response.

Abstract

Infliximab is highly effective in achieving clinical remission in patients with UC. However, the ability to keep sustained response seems to be lower as compared with Crohn’s disease patients.

Despite this fact, infliximab is very effective colon saving therapy.

Keywords

• ulcerative colitis
• infliximab
• sustained response
• colectomy